Researchers in the largest high blood pressure (BP) clinical trial ever are launching an outreach program to improve BP awareness and control across the country. About 150 physicians in 34 states and Washington, DC, have completed training to educate other local physicians. The goal is to help physicians and patients prevent high BP and treat it more effectively.
The outreach is a follow-up to the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT) and is being sponsored in cooperation with the National High BP Education Program. The ALLHAT study compared the effects of 4 major classes of medications to treat high BP, and more than 42,000 people aged 55 and older took part (December 2002 edition of the Journal of the American Medical Association).
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs